Authors: Vanessa Ngan, Staff Writer, 1998. Updated: Dr Nisal Punchihewa, Junior Medical Officer, Monash Medical Centre, Melbourne, Victoria, Australia; Dr Martin Keefe, Dermatologist and Assistant Editor. Copy edited by Gus Mitchell. February 2022
Pityriasis lichenoides (PL) is an uncommon cutaneousrash of uncertain aetiology. The acute form, pityriasis lichenoides et varioliformis acuta (PLEVA), and the chronic form, pityriasis lichenoides chronica (PLC), sit at either end of a disease spectrum with many patients showing overlapping features.
The eponym Mucha–Habermann disease is sometimes applied to the entire spectrum of PL but is often reserved for the particularly severe ulcero-necrotic variant of PLEVA.
Pityriasis lichenoides chronica images
Pityriasis lichenoides chronica on the chest
The mica-like scale in pityriasis lichenoides chronica
The incidence of PL is unknown, but the disease is rare. It is most common in children and young adults under age 30 but can present at any age. There is a slight male predominance. All races are affected.
What causes pityriasis lichenoides?
The cause of PL is unknown. The main hypotheses are that it may be:
A hypersensitivity reaction to an infection, such as:
Most cutaneous lesions heal with transient or persistent hyper- or hypo-pigmentation.
Constitutional symptoms are usually mild (see complications below).
PLC presents more slowly over several days with:
Larger numbers of small erythematous papules with a brown hue visible on diascopy
Mica-like scale on more established lesions
Lesions at various stages of evolution
Patients often experience periods of relapse and exacerbation.
Patients often show features of both PLEVA and PLC, and PLEVA may evolve into PLC. Mucosal lesions have been reported.
Pityriasis lichenoides acuta
Ulcerated pityriasis lichenoides acuta
Pityriasis lichenoides acuta on the arm
Pityriasis lichenoides acuta in a child
Ulcerated pityriasis lichenoides acuta on the arm
Mucosal ulcers in pityriasis lichenoides acuta
Eroded lesions in pityriasis lichenoides acuta
How do clinical features vary in differing types of skin?
Dark-skinned patients, particularly children, may present with widespread hypopigmentation and prominent facial involvement. The definitive signs of pityriasis lichenoides may be very subtle.
What are the complications of pityriasis lichenoides?
Ulceronecrotic lesions may heal with varioliform scarring.
A rare severe form of PLEVA (Febrile Ulceronecrotic Mucha–Habermann Disease) has systemic features of malaise, fever, lymphadenopathy, arthritis, and/or bacteraemia. There may be mucosal, gastrointestinal, and pulmonary involvement. Mortality up to 25% is reported.
The psychological impact should not be overlooked, particularly when skin lesions appear on more easily visible areas such as the face and upper arms.
How is pityriasis lichenoides diagnosed?
The diagnosis can often be made on clinical grounds but is usually confirmed with a skin biopsy, which helps to exclude other important differential diagnoses.
Histological features of PLEVA include:
A wedge-shaped deep dermal and superficial lymphohistiocyticinfiltrate
Parakeratotic scale and crust, with thinning of the granular layer
Interfacedermatitis with basal cell necrosis and vacuolation
Epidermalspongiosis and necrosis in more developed lesions
It is important to recognise that there have been no randomised controlled trials regarding treatment, and the natural history of pityriasis lichenoides makes interpretation of anecdotal reports difficult.
PLEVA is most commonly treated with prolonged courses of erythromycin (in young children) or doxycycline. They are used for their anti-inflammatory effects rather than their antibacterial properties.
Pityriasis lichenoides et varioliformis acuta typically resolves within a few weeks. However, this can be variable and PLEVA may evolve into PLC or a scar. Pityriasis lichenoides chronica typically lasts several months, but some cases can wax and wane for several years.
Ankad BS, Beergouder SL. Pityriasis lichenoides et varioliformis acuta in skin of color: new observations by dermoscopy. Dermatol Pract Concept. 2017;7(1):27–34. Published 2017 Jan 31. doi:10.5826/dpc.0701a05. Journal
Bellinato F, Maurelli M, Gisondi P, Girolomoni G. A systematic review of treatments for pityriasis lichenoides. J Eur Acad Dermatol Venereol. 2019;33(11):2039–49. doi:10.1111/jdv.15813. Journal
Bowers S, Warshaw EM. Pityriasis lichenoides and its subtypes. J Am Acad Dermatol. 2006;55(4):557–76. doi:10.1016/j.jaad.2005.07.058. Journal
Jowkar F, Namazi MR, Bahmani M, Monabati A. Triggering of pityriasis lichenoides et varioliformis acuta by radiocontrast iodide. J Dermatolog Treat. 2008;19(4):249–50. doi:10.1080/09546630701713493. Journal
Jung F, Sibbald C, Bohdanowicz M, Ingram JR, Piguet V. Systematic review of the efficacies and adverse effects of treatments for pityriasis lichenoides. Br J Dermatol. 2020;183(6):1026–32. doi:10.1111/bjd.18977. Journal
Khachemoune A, Blyumin ML. Pityriasis lichenoides: pathophysiology, classification, and treatment. Am J Clin Dermatol. 2007;8(1):29–36. doi:10.2165/00128071-200708010-00004. Journal
Lane TN, Parker SS. Pityriasis lichenoides chronica in black patients. Cutis. 2010;85(3):125–9. Journal
Magro C, Guo R, Nguyen GH, Tsang H, Momtahen S. Pityriasis lichenoides-like drug reaction: A clinical histopathologic study of 10 cases. Dermatol Online J. 2017;23(11):13030/qt7xd8j71z. Published 2017 Nov 15. Journal